Resveratrol Reduce the Severity of Anemia and Thrombocytopenia in Plasmodium berghei ANKA-Infected Mice
Downloads
Background: Malaria is an infectious disease with a high mortality rate. One of the complications of malaria is blood disorders. Hematological disorders such as anemia and thrombocytopenia are common in malaria infection. Resveratrol has been reported to have antimalarial activity. Objective: This study aimed to evaluate the effect of resveratrol in reducing the severity of anemia and thrombocytopenia in Plasmodum berghei-infected mice. Methods: The study began with parasite inoculation in mice. After the mice were infected, and randomly grouped into negative control, chloroquine 20 mg/kg (positive control), and resveratrol with doses 25, 50, and 100 mg/kg. The mice's blood profile was measured on day 0 and day 4 using a hematology analyzer. Results: The results showed that after administration of resveratrol at various doses, the number of RBC, hemoglobin, hematocrit and platelets was higher than the control. Conclusion: It can be concluded that resveratrol can reduce the severity of anemia and thrombocytopenia in mice infected with P. berghei.
Akinosoglou, K. S., Solomou, E. E. & Gogos, C. A. (2012). Malaria: A Haematological Disease. Hematology; 17; 106–114. doi: 10.1179/102453312X13221316477336.
Awoke, N. & Arota, A. (2019). Profiles of Hematological Parameters in Plasmodium falciparum and Plasmodium vivax Malaria Patients Attending Tercha General Hospital, Dawuro Zone, South Ethiopia. Infection and Drug Resistance; 12; 521–527. doi: 10.2147/IDR.S184489.
Balaji, S., Deshmukh, R. & Trivedi, V. (2020). Severe Malaria: Biology, Clinical Manifestation, Pathogenesis and Consequences. Journal of Vector Borne Diseases; 57; 1–13. doi: 10.4103/0972-9062.308793.
Balaji, S. N. & Trivedi, V. (2012). Extracellular Methemoglobin Mediated Early ROS Spike Triggers Osmotic Fragility and RBC Destruction: An Insight into the Enhanced Hemolysis During Malaria. Indian Journal of Clinical Biochemistry (IJCB); 27; 178–185. doi: 10.1007/S12291-011-0176-5.
Bhutani, A., Kaushik, R. M., & Kaushik, R. (2020). A Study on Multi-Organ Dysfunction Syndrome in Malaria Using Sequential Organ Failure Assessment Score. Tropical Parasitology; 10; 86–94. doi: 10.4103/tp.TP_12_19.
Dondorp, A. M., Nosten, F., Yi, P., Das, D., Phyo, A. P., Tarning, J., Lwin, K. M., Ariey, F., Hanpithakpong, W., Lee, S. J., Ringwald, P., Silamut, K., Imwong, M., Chotivanich, K., Lim, P., Herdman, T., An, S. S., Yeung, S., Singhasivanon, P. & White, N. J. (2009). Artemisinin Resistance in Plasmodium falciparum Malaria. New England Journal of Medicine; 361; 455–467. doi: 10.1056/nejmoa0808859.
Galiniak, S., Aebisher, D., & Bartusik-Aebisher, D. (2019). Health Benefits of Resveratrol Administration. Acta Biochimica Polonica; 66; 13–21. doi: 10.18388/abp.2018_2749.
Gil, J. P. & Krishna, S. (2017). Pfmdr1 (Plasmodium falciparum Multidrug Drug Resistance Gene 1): a Pivotal Factor in Malaria Resistance to Artemisinin Combination Therapies. Expert Review of Anti-Infective Therapy; 15; 527–543. doi: 10.1080/14787210.2017.1313703.
Gomes, A. R. Q., Cunha, N., Varela, E. L. P., Brígido, H. P. C., Vale, V. V., Dolabela, M. F., De Carvalho, E. P. & Percário, S. (2022). Oxidative Stress in Malaria: Potential Benefits of Antioxidant Therapy. International Journal of Molecular Sciences; 23; 1-26. doi: 10.3390/ijms23115949.
Hasugian, A., H, W., & Tjitra, E. (2014). In Vivo Antimalarial Efficacy of Acetogenins, Alkaloids and Flavonoids Enriched Fractions from Annona crassiflora Mart. Natural Product Research; 28; 1254–1259. doi: 10.1080/14786419.2014.900496.
Hasugian, A., Wibowo, H. & Tjitra, E. (2015). Peranan Trombosit dalam Patogenesis Malaria. Majalah Kedokteran Andalas; 37; 219-225. doi: 10.22338/mka.v37.i3.p219-225.2014.
Hermanto, F., Nur Anisa, I., Wahyuningsih, S., Alatas, F., Suryani, S., Rachmawan, R. L., Ahsanul Haq, F. & Adhary, F. (2022). Antiplasmodium Activity and the Effect of Resveratrol on Index Organs of Mice Infected with Plasmodium berghei ANKA. PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia); 19; 28-39. doi: 10.30595/pharmacy.v19i1.12693.
Intan, P. R., Lestari, T. W. & Sani, Y. (2017). Histopathological Study After Delivery Mixed Extract of Alstonia scholaris Bark and Phyllanthus niruri Administration in Plamodium berghei Infected mice. Jurnal Kedokteran Yarsi; 25; 10–22.
Lee, S. H., Looareesuwan, S., Chan, J., Wilairatana, P., Vanijanonta, S., Chong, B. & Chong, H. (1997). Plasma Macrophage Colony-Stimulating Factor and P-selectin Levels in Malaria-Associated Thrombocytopenia. Thromb Haemost; 77; 289-293.
Moon, H. I., & Sim, J. (2008). Antimalarial Activity in Mice of Resveratrol Derivative from Pleuropterus ciliinervis. Annals of Tropical Medicine and Parasitology; 102; 447–450. doi: 10.1179/136485908X300832.
Rifkind, J. M., Mohanty, J. G. & Nagababu, E. (2015). The Pathophysiology of Extracellular Hemoglobin Associated with Enhanced Oxidative Reactions. Frontiers in Physiology; 5; 1-7. doi: 10.3389/FPHYS.2014.00500.
Wassmer, S. C., Taylor, T., MacLennan, C. A., Kanjala, M., Mukaka, M., Molyneux, M. E. & Grau, G. E. (2008). Platelet-Induced Clumping of Plasmodium falciparum-Infected Erythrocytes from Malawian Patients with Cerebral Malaria-Possible Modulation In Vivo by Thrombocytopenia. The Journal of Infectious Diseases; 197; 72–78. doi: 10.1086/523761.
Wickramasinghe, S. N. & Abdalla, S. H. (2000). Blood and Bone Marrow Changes in Malaria. Bailliere's Best Practice and Research in Clinical Haematology; 13; 277–299. doi: 10.1053/beha.1999.0072.
World Health Organization. (2022). World Malaria Report 2022. In: World Health 12. Geneva: World Health Organization.
Copyright (c) 2023 JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. The copyright of this journal belongs to the Editorial Board and Journal Manager with the author's knowledge, while the moral right of the publication belong to the author.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
.jpg)
